Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
PetMed Express, Inc. Announces Management Changes
-
Solid Biosciences Reports Second Quarter 2025 Financial Results and Provides Business Updates
-
SoundThinking, Inc. Reports Second Quarter 2025 Financial Results
-
ImmuCell Announces Bank Debt Refinancing
-
Rekor Systems Reports Second Quarter 2025 Financial Results
-
Urgently Announces Second Quarter 2025 Financial Results
-
Pioneer Acquisition I Corp Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing on or about August 15, 2025
-
Prairie Operating Co. Announces Second Quarter 2025 Results
-
Rigetti Computing Reports Second Quarter 2025 Financial Results; Announces General Availability of its 36-Qubit Multi-Chip Quantum Computer
-
Zevra Reports Second Quarter 2025 Financial Results and Corporate Update
-
CNB Financial Corporation Announces Quarterly Dividend for Common Stock
-
Diginex Announces MOU for US$305m Acquisition of Findings, a leading cybersecurity and compliance automation company
-
ARRAY Technologies, Inc. to Participate in Upcoming Investor Conferences and Events
-
Arbor Realty Trust Closes a $1.05 Billion Collateralized Loan Obligation Securitization
-
Cue Biopharma Reports Second Quarter 2025 Financial Results and Recent Business Highlights
-
LogicMark, Inc. Reports Second Quarter 2025 Results Highlighted by 22% Sales Growth
-
H&R Block Reports Fiscal 2025 Results and Provides Fiscal 2026 Outlook
-
NeuroPace Reports Second Quarter 2025 Financial Results and Increases 2025 Revenue Guidance
-
Highwoods Recasts Term Loan
-
Caribou Biosciences Reports Second Quarter 2025 Financial Results and Provides Business Update
-
SELLAS Life Sciences Reports Second Quarter 2025 Financial Results and Provides Corporate Update
-
Playboy Reports Second Quarter 2025 Financial Results
-
Cytek Biosciences to Participate in Upcoming Investor Conferences
-
SKYX Reports Increase of 15% with Record Second Quarter 2025 Revenues of $23.1 Million Compared to $20.1 Million for First Quarter 2025 as it Continues to Grow its Market Penetration in the U.S. and C
-
OnKure Therapeutics Reports Second Quarter 2025 Financial Results and Provides a Business Update
-
Mineralys Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update
-
AEON Biopharma Reports Second Quarter 2025 Financial Results and Provides Corporate Update
-
Beyond Air® Reports Fiscal First Quarter 2026 Financial Results and Provides Corporate Update
-
Anterix Inc. Reports First Quarter Fiscal Year 2026 Results
-
High Roller Reports Q2 2025 Results
-
NEXGEL Reports Second Quarter 2025 Financial Results
-
BioRestorative Therapies Reports Second Quarter 2025 Financial Results and Provides Business Update
-
Fold Holdings, Inc. (NASDAQ: FLD) Announces Second Quarter 2025 Results
-
Pharvaris Reports Second Quarter 2025 Financial Results and Provides Business Update
-
Generation Bio Announces New Data for Its Novel ctLNP Delivery System and Early T Cell Programs and Reports Second Quarter 2025 Financial Results
-
Metagenomi Reports Business Updates and Second Quarter 2025 Financial Results
-
Inspirato Reports Q2 Financial and Operating Results
-
WEBTOON Entertainment Inc. Reports Second Quarter 2025 Financial Results
-
Annovis Provides Corporate Updates and Reports Second Quarter 2025 Financial Results
-
Mobile Infrastructure Reports Second Quarter 2025 Financial Results
-
Iridex Reports Second Quarter 2025 Financial Results
-
Alico, Inc. Announces Financial Results for the Third Quarter Ended June 30, 2025
-
Slide Reports Second Quarter 2025 Results
-
Fractyl Health Announces Second Quarter 2025 Financial Results and Business Updates
-
DeFi Development Corp. Announces Second Quarter 2025 Earnings
-
Varonis to Present at Upcoming Investor Conference
-
Adagene Reports Six Months 2025 Financial Results and Provides Corporate Updates
-
Lyell Immunopharma Reports Business Highlights and Financial Results for the Second Quarter 2025
-
ORIC® Pharmaceuticals Reports Second Quarter 2025 Financial Results and Operational Updates
-
ALX Oncology Reports Second Quarter 2025 Financial Results and Provides Corporate Update
